The cystic fibrosis transmembrane conductance regulator (CFTR) is a protein that belongs to the superfamily of ATP binding cassette (ABC) transporters. Mutations in the CFTR gene cause cystic fibrosis, an autosomal recessive disorder. The function of CFTR is versatile. It can serve as a regulatory protein, as a membrane transporter and as an ion channel. Dimerization of CFTR is necessary for full ion channel function although structural details of CFTR in native membrane are yet unknown. In order to identify CFTR in native plasma membrane we applied atomic force microscopy (AFM) to inside-out oriented membrane patches of CFTR-expressingXenopus laevis oocytes after cAMP stimulation. First, oocytes were injected with CFTR-cRNA and, three days later, voltage-clamped verifying successful CFTR expression and incorporation into the plasma membrane. Then, plasma membrane patches were isolated, placed inside-out on appropriate substrate and incubated with gold-labelled antibodies against the C-terminus of CFTR. Finally, the intracellular surface of the plasma membrane was scanned by AFM. In close vicinity to the immunogold labels we detected ring-like structures with bipartite symmetry. The substructure of the ring, formed by the extramembrane protein domains of CFTR, is consistent with the model of a CFTR dimer. Derived from AFM molecular mass analysis of the intramolecular domains we conclude that two CFTR molecules line up in parallel, tail by tail, forming a pore in its center. This molecular arrangement could represent the CFTR chloride channel configuration, operative in native plasma membrane.

This content is only available via PDF.
© 2004 S. Karger AG, Basel
2004
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.